Research Catalog

Guidance for industry : potassium chloride modified-release tablets and capsules, in vivo bioequivalence and in vitro dissolution testing.

Title
Guidance for industry : potassium chloride modified-release tablets and capsules, in vivo bioequivalence and in vitro dissolution testing.
Publication
Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, [2005]

Available Online

https://purl.fdlp.gov/GPO/LPS117081

Details

Additional Authors
Center for Drug Evaluation and Research (U.S.). Office of Generic Drugs.
Description
1 online resource (10 pages)
Alternative Title
Potassium chloride modified-release tablets and capsules, in vivo bioequivalence and in vitro dissolution testing
Subject
  • Potassium chloride
  • Drugs > Therapeutic equivalency > Government policy > United States
  • Tablets (Medicine) > Testing > Government policy > United States
  • Capsules (Pharmacy) > Testing > Government policy > United States
Note
  • "OGD."
  • "October 2005."
Bibliography (note)
  • Includes bibliographical references (page 9).
Call Number
GPO Internet HE 20.4702:P 84/4
OCLC
marcive471916929
Title
Guidance for industry : potassium chloride modified-release tablets and capsules, in vivo bioequivalence and in vitro dissolution testing.
Publisher
Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, [2005]
Type of Content
text
Type of Medium
computer
Type of Carrier
online resource
Bibliography
Includes bibliographical references (page 9).
Connect to:
https://purl.fdlp.gov/GPO/LPS117081
Added Author
Center for Drug Evaluation and Research (U.S.). Office of Generic Drugs.
Gpo Item No.
0499-T (online)
Sudoc No.
HE 20.4702:P 84/4
View in Legacy Catalog